Evidence map›Paper›PMID 32348434›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2020

Evaluation of the effect of intraperitoneal etanercept administration on oxidative stress and inflammation indicators in the kidney and blood of experimental sepsis-induced rats.

Emre Aydın, Yaşar Yıldırım, Fatma Yılmaz Aydın, Mehmet Veysi Bahadır, İbrahim Kaplan, Berfin Kadiroğlu, Muzaffer Aydın Ketani, Zülfükar Yılmaz, Ali Kemal Kadiroğlu, Mehmet Emin Yılmaz

Open access · diamondAbstract read
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Emre AydınDepartment of Nephrology, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Yaşar YıldırımDepartment of Nephrology, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Fatma Yılmaz AydınDepartment of Internal Medicine, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Mehmet Veysi BahadırDepartment of General Surgery, School of Medicine, University of Dicle, Diyarbakır, Turkey.
İbrahim KaplanDepartment of Biochemistry, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Berfin KadiroğluDepartment of Virology, School of Veterinary Medicine, University of Dicle, Diyarbakır, Turkey.
Muzaffer Aydın KetaniDepartment of Histology and Embryology, School of Veterinary Medicine, University of Dicle, Diyarbakır, Turkey.
Zülfükar YılmazDepartment of Nephrology, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Ali Kemal KadiroğluDepartment of Nephrology, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Mehmet Emin YılmazDepartment of Nephrology, School of Medicine, University of Dicle, Diyarbakır, Turkey.
Dicle University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSepsis is an important cause of mortality and morbidity, and inflammatory response and oxidative stress play major roles underlying its pathophysiology. Here, we evaluated the effect of intraperitoneal etanercept administration on oxidative stress and inflammation indicators in the kidney and blood of experimental sepsis-induced rats.

methodsTwenty-eight adult Sprague Dawley rats were classified into Control (Group 1), Sepsis (Group 2), Sepsis+Cefazolin (Group 3), and Sepsis+Cefazolin+Etanercept (Group 4) groups. Kidney tissue and serum samples were obtained for biochemical and histopathological investigations and examined for the C reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), triggering receptor expressed on myeloid cells (TREM), and malondialdehyde (MDA) levels.

resultsThe levels of TNF-α, TREM, and MDA in serum and kidney samples were significantly higher in rats from sepsis group than in rats from control group (p < 0.05). Group 3 showed a significant reduction in serum levels of TNF-α, CRP, and TREM as compared with Group 2 (p < 0.05). Serum TNF-α, CRP, TREM, and MDA levels and kidney TNF-α and TREM levels were significantly lower in Group 4 than in Group 2 (p < 0.05). Serum TNF-α and TREM levels in Group 4 were significantly lower than those in Group 3, and histopathological scores were significantly lower in Group 3 and Group 4 than in Group 2 (p < 0.05). Histopathological scores of Group 4 were significantly lower than those of Group 3 (p < 0.05).

conclusionsEtanercept, a TNF-α inhibitor, may ameliorate sepsis-induced oxidative stress, inflammation, and histopathological damage.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalDisease Models, AnimalEtanerceptInflammationInjections, IntraperitonealKidneyOxidative StressRatsRats, Sprague-DawleySepsisTumor Necrosis Factor-alphaAnti-Inflammatory Agents, Non-SteroidalEtanerceptTumor Necrosis Factor-alpha

Identifiers

PMID32348434
PMCPMC7198067
OpenAlexW3017963093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.